Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,126.07
812.03
942.16
1,078.45
1,020.76
732.04
853.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,126.07
812.03
942.16
1,078.45
1,020.76
732.04
853.11
Raw Material Cost
245.62
201.74
194.81
162.58
244.91
165.52
247.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.76
0.64
1.66
1.09
0.51
0.00
0.10
Selling and Distribution Expenses
572.13
418.72
509.59
590.83
506.12
408.01
404.31
Other Expenses
3.07
6.14
3.74
3.67
1.98
5.32
2.34
Total Expenditure (Excl Depreciation)
849.24
682.46
743.42
791.17
771.32
626.73
674.83
Operating Profit (PBDIT) excl Other Income
276.8
129.60000000000002
198.70000000000002
287.3
249.4
105.3
178.29999999999998
Other Income
22.57
12.74
19.03
27.41
19.25
53.68
19.88
Operating Profit (PBDIT)
285.44
157.69
231.70
324.54
278.48
177.96
207.36
Interest
0.76
0.64
1.66
1.09
0.51
0.00
0.10
Exceptional Items
0.83
-8.13
2.80
-1.62
-0.38
3.64
-1.34
Gross Profit (PBDT)
880.45
610.29
747.35
915.87
775.85
566.52
606.05
Depreciation
0.00
26.75
26.75
23.89
23.89
19.06
19.96
Profit Before Tax
285.51
122.17
206.08
297.93
253.70
162.53
185.97
Tax
38.07
13.00
28.34
38.74
36.94
13.79
25.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
246.33
108.57
176.55
257.57
216.82
148.68
160.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
246.33
108.57
176.55
257.57
216.82
148.68
160.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.11
0.34
1.12
1.57
-0.08
-0.00
-0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
247.44
108.91
177.67
259.13
216.73
148.68
160.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,648.87
3,400.58
3,248.24
3,066.39
3,311.52
3,072.53
2,893.84
Earnings per share (EPS)
0.43
0.19
0.31
0.45
0.38
0.26
0.28
Diluted Earnings per share
0.43
0.19
0.31
0.45
0.38
0.26
0.28
Operating Profit Margin (Excl OI)
23.34%
14.56%
19.73%
25.34%
23.05%
14.37%
19.64%
Gross Profit Margin
25.35%
18.34%
24.71%
29.84%
27.19%
24.81%
24.14%
PAT Margin
21.88%
13.37%
18.74%
23.88%
21.24%
20.31%
18.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 10.32% vs 13.95% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 14.17% vs 13.87% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 1.43% vs 17.07% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 60.00% vs 400.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Henan Lingrui Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,126.07
0
1,126.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,126.07
0
1,126.07
Raw Material Cost
245.62
0
245.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.76
0
0.76
Selling and Distribution Expenses
572.13
0
572.13
Other Expenses
3.07
0.00
3.07
Total Expenditure (Excl Depreciation)
849.24
0
849.24
Operating Profit (PBDIT) excl Other Income
276.84
0.00
276.84
Other Income
22.57
0
22.57
Operating Profit (PBDIT)
285.44
0
285.44
Interest
0.76
0
0.76
Exceptional Items
0.83
0
0.83
Gross Profit (PBDT)
880.45
0
880.45
Depreciation
0.00
0
0.00
Profit Before Tax
285.51
0
285.51
Tax
38.07
0
38.07
Provisions and contingencies
0
0
0.00
Profit After Tax
246.33
0
246.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
246.33
0
246.33
Share in Profit of Associates
0
0
0.00
Minority Interest
1.11
0
1.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
247.44
0
247.44
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,648.87
0
3,648.87
Earnings per share (EPS)
0.43
0
0.43
Diluted Earnings per share
0.43
0
0.43
Operating Profit Margin (Excl OI)
23.34%
0%
0.00
23.34%
Gross Profit Margin
25.35%
0%
0.00
25.35%
PAT Margin
21.88%
0%
0.00
21.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 112.61 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 38.68% vs -13.82% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 10.32% vs 13.95% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 24.74 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 127.18% vs -38.72% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 14.17% vs 13.87% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.29 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 81.31% vs -31.83% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.43% vs 17.07% in Mar 2025
Quarterly - Interest
Interest 0.08 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 33.33% vs -64.71% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 60.00% vs 400.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.34%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
